What is Tissue Analytics?
Tissue Analytics, Inc. is a Baltimore-based health technology firm specializing in artificial intelligence-powered software designed to optimize clinical documentation and electronic medical record (EMR) data quality. By utilizing sophisticated computer vision, the platform provides clinicians, researchers, and industry stakeholders with precise, automated wound management tools. The company distinguishes itself through its seamless integration capabilities, utilizing SMART on FHIR standards to embed its solutions directly into industry-leading platforms such as Epic, Cerner, and Allscripts. This interoperability ensures that healthcare providers can maintain high-quality data workflows without disrupting existing clinical processes, ultimately improving patient outcomes and operational efficiency across diverse therapy areas.
How much funding has Tissue Analytics raised?
Tissue Analytics has raised a total of $7.7M across 3 funding rounds:
Angel/Seed
$750K
Debt
$1.9M
Series A
$5M
Angel/Seed (2015): $750K with participation from Tencent and DreamIt Health
Debt (2016): $1.9M, investors not publicly disclosed
Series A (2018): $5M supported by Intermountain Health, Tencent, Dreamit Ventures, Molnlycke Health Care, DigiTx Partners, and Penn Medicine
Key Investors in Tissue Analytics
Tencent
Tencent is a global technology conglomerate that develops digital platforms and internet-based services, including artificial intelligence and enterprise solutions, while actively investing in high-growth technology innovation.
DreamIt Health
Dreamit is a top-ranked global accelerator and venture capital firm that drives business velocity for startups by providing access to investors, sales pipelines, and extensive industry networks.
Molnlycke Health Care
Headquartered in Sweden, Molnlycke Health Care is a leading manufacturer and marketer of advanced wound care and single-use surgical products, providing deep domain expertise to its portfolio companies.
What's next for Tissue Analytics?
With the successful completion of its recent strategic financing, Tissue Analytics is well-positioned to accelerate its market penetration and expand its technological footprint. The company is expected to focus on enhancing its machine learning algorithms to support broader diagnostic capabilities and deeper integration with enterprise-level healthcare systems. As the digital health sector continues to prioritize data-driven clinical decision support, Tissue Analytics is poised to leverage its existing partnerships with major health systems and global technology investors to scale its reach. Future strategic initiatives will likely center on increasing the adoption of its wound management platform, further refining its EMR integration suite, and exploring new therapeutic applications for its computer vision technology to maintain its competitive edge in the rapidly evolving health-tech market.
See full Tissue Analytics company page
